Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(7 sites)
United States
Memorial Sloan Kettering at Basking Ridge (Consent Only), Basking Ridge, New Jersey Memorial Sloan Kettering Monmouth (Consent Only), Middletown, New Jersey Memorial Sloan Kettering Bergen (Consent Only), Montvale, New Jersey Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Consent only), Commack, New York Memorial Sloan Kettering Westchester (Consent only), Harrison, New York Memorial Sloan Kettering Cancer Center (All protocol activities), New York, New York Memorial Sloan Kettering Cancer Center @ Nassau (Consent only), Uniondale, New York